Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BBIO · against 134 other Healthcare companies of similar size
Ranked #132 of 135 · scores higher than 2% of peers · safety percentile 5
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)11 peers with a safety percentile of 0–9, including BBIO · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | BBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 127 reported | Not reported | 0.34× | — | — | 33% |
| BetaLower is better · 134 reported | 0.97 | 0.65 | 26% | 33% | |
| Current ratioHigher is better · 128 reported | 1.23× | 2.25× | 17% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 9.0B USD | 98 | 51 | |
| 3 | 10.2B USD | 97 | ||
| 4 | 9.8B USD | 96 | ||
| 5 | 8.8B USD | 94 | 50 | |
| 128 | 11.6B USD | 6 | 57 | |
| 129 | 8.8B USD | 6 | 31 | |
| 130 | 7.3B USD | 6 | 32 | |
| 131 | 23.5B USD | 5 | 27 | |
| 132 | 14.5B USD | 5 | 30 | |
| 133 | 21.5B USD | 3 | 60 | |
| 134 | 14.0B USD | 2 | 31 | |
| 135 | 16.5B USD | 0 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score